Piscataway-based GenScript USA Inc. said Monday that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for the cPass™ SARS-CoV-2 Neutralization Antibody Detection ...
Phase 2 clinical trial will evaluate the safety, translational biology, and exploratory clinical efficacy of VYD2311 in people with Long COVID or ...
An antibody developed by researchers works against a wide range of COVID-19 variants and related coronaviruses, including past, present and potentially future strains. A monoclonal antibody appears ...
PLYMOUTH MEETING, Pa., May 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ:INO) today announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA vaccine, demonstrating robust ...
Scientists have identified a new pair of antibodies that could fend off multiple COVID-19 variants. Found in people who successfully recovered from the illness, these antibodies attach to a part of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results